Myasthenia Gravis in Dogs: Symptoms, Diagnosis, and Treatment

Myasthenia gravis (MG) is a neuromuscular disease that disrupts communication between nerves and muscles, producing weakness that worsens with activity and improves with rest. In dogs, it is most often an acquired autoimmune condition — the immune system mistakenly attacks the receptors muscles need to receive nerve signals. Understanding how MG presents, how it is diagnosed, and what treatment and management involve can help owners navigate a complex but often manageable condition.

What Is Myasthenia Gravis?

At the junction between nerve endings and muscle fibers, nerve signals are transmitted by a chemical called acetylcholine (ACh), which binds to receptors on the muscle surface and triggers contraction. In myasthenia gravis, autoantibodies attack and destroy these acetylcholine receptors.

With fewer functional receptors available, the muscle cannot respond normally to nerve signals. The result is weakness that becomes progressively more pronounced with sustained or repeated activity, and that partially recovers after the dog rests and nerve signals can accumulate again.

According to Cornell University College of Veterinary Medicine¹, myasthenia gravis in dogs occurs in two forms: acquired (autoimmune) and congenital.

Acquired vs. Congenital Myasthenia Gravis

Acquired MG is by far the more common form. It is an autoimmune condition that can arise at any age, though it is most commonly diagnosed in middle-aged and older dogs. In some cases, acquired MG is associated with a thymoma (a tumor of the thymus gland) or other underlying disease, making a thorough diagnostic workup important.

Congenital MG is a rare hereditary form in which dogs are born without adequate acetylcholine receptors due to a genetic defect rather than an autoimmune attack. This form has been identified in Jack Russell Terriers, Springer Spaniels, and Smooth Fox Terriers, among others. Because there are no autoantibodies present, the AChR antibody titer test is negative — congenital MG requires genetic or electrophysiological testing for confirmation.

Signs and Symptoms

Generalized Myasthenia Gravis

Generalized MG produces weakness across multiple muscle groups. The hallmark is exercise-induced weakness — a dog may begin walking normally but slow down, wobble, or sit abruptly after a short period of exertion, then improve after resting for several minutes.

Other signs include: - Collapse during or after activity - Difficulty swallowing - Voice changes or altered bark - Regurgitation of undigested food (a key distinction from vomiting — there is no retching, and the food appears tubular and undigested) - Drooling - Megaesophagus (see below)

Focal Myasthenia Gravis

In focal MG, weakness is confined to specific muscle groups, most commonly the esophagus. Dogs with focal MG may walk normally but experience significant regurgitation due to esophageal muscle failure. Facial muscle weakness and voice changes can also appear in isolation. Because gait is normal, focal MG is often diagnosed later than the generalized form.

Myasthenia Gravis and Megaesophagus

Megaesophagus is a dilation of the esophagus that occurs when esophageal muscles lose the strength to move food into the stomach. The esophagus balloons outward and food pools inside it, eventually being regurgitated.

According to VCA Animal Hospitals², megaesophagus occurs in the majority of dogs with generalized MG and is a significant source of morbidity. The most dangerous complication is aspiration pneumonia: regurgitated material that is inhaled into the lungs causes a severe, life-threatening lung infection that is the leading cause of death in dogs with myasthenia gravis.

Regurgitation — passive return of food from the esophagus without retching — is distinct from vomiting and should prompt evaluation for megaesophagus, particularly in dogs already known to have MG.

Diagnosing Myasthenia Gravis in Dogs

AChR Antibody Titer: The most definitive diagnostic test is a blood test that measures the level of antibodies against acetylcholine receptors. A positive titer confirms acquired MG. This test is submitted to a specialized laboratory and typically takes several days to return.

Neostigmine or Edrophonium (Tensilon) Challenge: A short-acting anticholinesterase drug is administered; if muscle strength visibly improves within minutes, the result supports a MG diagnosis. This test provides rapid information while titer results are pending.

Thoracic Radiographs: Chest X-rays are performed to evaluate for megaesophagus and to screen for aspiration pneumonia. Identifying either finding significantly affects prognosis and management.

CT or Chest Imaging: If a thymoma is suspected as an underlying cause, advanced imaging of the chest may be recommended.

Treatment

Pyridostigmine bromide (Mestinon) is the primary treatment for myasthenia gravis in dogs. It is an anticholinesterase medication that slows the breakdown of acetylcholine at the neuromuscular junction, allowing the available receptors to be activated more effectively. Most dogs show noticeable improvement in weakness within the first few days of treatment.

Immunosuppressive therapy: Because acquired MG is autoimmune, medications that reduce antibody production — such as corticosteroids, azathioprine, or mycophenolate — may be added when the autoimmune activity is not controlled by pyridostigmine alone or when the AChR antibody titer remains elevated.

Thymoma management: In dogs where MG is associated with a thymoma, surgical removal of the thymus gland is often pursued and can lead to MG improvement or remission.

Managing Megaesophagus at Home

Dogs with megaesophagus require specific management to reduce the risk of aspiration pneumonia:

Elevated feeding: Food and water should be offered from an elevated height — ideally with the dog in an upright or near-vertical position — to use gravity to move food toward the stomach

Bailey Chair: A specialized chair that holds the dog in an upright sitting position during and after meals is one of the most effective tools for managing megaesophagus

Post-meal positioning: Keep the dog upright for 20–30 minutes after every meal

Food texture: Soft, moist, or liquefied food often passes through the esophagus more easily than dry kibble; some dogs do better with small frequent meals

Knowing when to seek emergency care is particularly important for dogs with megaesophagus — aspiration pneumonia can develop quickly and requires urgent veterinary treatment.

Prognosis

The prognosis for dogs with acquired myasthenia gravis is variable. A meaningful proportion of dogs treated appropriately achieve spontaneous remission — the autoimmune attack subsides, the AChR antibody titer normalizes, and medication can be tapered. Remission typically takes several months to occur and requires monitoring titer levels over time.

The primary risk to survival is aspiration pneumonia. Dogs that are successfully managed with elevated feeding protocols and monitored closely for early signs of respiratory compromise have a significantly better outlook.

What pet insurance covers varies by plan, but broad accident and illness policies typically help cover the diagnostics, hospitalization, specialist referral, and prescription medications central to myasthenia gravis management.

The cost of pet care can add up quickly, especially during emergencies or for ongoing treatment. Choosing a plan with affordable monthly premiums and a simple reimbursement process can help reduce financial stress.

With Spot Pet Insurance, pet parents can access customizable plans designed to fit different budgets. Spot has paid back over $530 million in covered vet bills and offers quick claims processing, helping pet parents get reimbursed faster for eligible expenses. Learn more about what pet insurance covers.